EMA backs approving Sanofi's Dupixent for 'smoker's lungs',

Sanofi and partner
Regeneron Pharmaceuticals have secured the European
regulator's backing for use of Dupixent in patients with a
chronic lung disease even as the U.S. Food and Drug
Administration ...

Related Keywords

Bengaluru , Karnataka , India , France , French , Leroy Leo , Devika Syamnath , Tassilo Hummel , Diana Mandi , Regeneron Pharmaceuticals , Reuters , European Commission , Committee For Medicinal Products Human , Drug Administration , European Medicines Agency , Medicinal Products ,